HIV/AIDS Studies
Antiviral Properties and Benefits of Fulvic and Humic Acids in the Treatment of HIV
Humic and fulvic acids, as well as their derivatives such as oxyhumate and shilajit, offer great potential in the management of viral infections such as HIV, acting not only as antivirals but also as immunomodulators and detoxifiers. These advances open a promising door towards complementary therapies based on natural compounds. 🌿
1. Treatment of HIV with Humic Acids
Conclusion: Humic acids, specifically fulvic acids, have been shown to be effective and safe in eliminating the HIV/AIDS virus. A pharmaceutical company has patented a drug based on humic compounds that purifies blood for transfusions and eliminates the HIV virus without damaging blood cells.
Document Type: Patent
Link: Patent - US20040137085A1
2. Antiviral properties against HIV-1
Conclusion: Natural humic substances, such as humic acids, have significant antiviral properties against HIV-1. Compared to shilajit, humic acids show a superior molecular composition for these applications.
Document Type: Peer-reviewed journal article
Link: NCBI - PMC7554000
3. Reducing ART Resistance with Shilajit
Conclusion: Shilajit (Shilajatu Rasayana) may decrease recurrent HIV resistance to antiretroviral therapy (ART) and improve ART outcomes in HIV-infected patients.
Document Type: Peer-reviewed journal article
Link: NCBI - PMC3215318
4. Interference with HIV multiplication
Conclusion: Humic substances, including humic and hymatomelanic acids, exhibit significant antiviral activity at several stages of the HIV replication cycle. They inhibit fusion, reverse transcription and integration of viral DNA, and block HIV-1 binding to host cells.
Document Type: Conference Summary
Link: Sci -Hub - Antiviral Activity of Humic Substances
5. Anti-HIV Properties of Oxyhumate
Conclusion: Oxyhumate effectively inhibits HIV-1 infection by blocking CD4 binding and the V3 loop-mediated viral entry step. Furthermore, no viral resistance to oxyhumate was observed over a 12-week period in vitro.
Document Type: Peer-reviewed journal article
Link: ResearchGate - Anti -HIV Properties of Oxyhumate
6. Stimulation of the Immune System in Immunocompromised Patients
Conclusion: Oxyhumate has been shown to stimulate the proliferative response of human lymphocytes in immunocompromised individuals, including HIV patients. These effects have been observed in both in vitro and ex vivo studies, where doses of 4 g/day of oxyhumate showed promising results without toxicity.
Document Type: Peer-reviewed journal article
Link: NCBI - Immunostimulant Properties of Oxyhumate
